Articles

Top Of Mind Political Risks: February 2024

Country Risk / Global / Fri 02 Feb, 2024

Near-Term Political Events To Watch
Event/DevelopmentDateImpactImplications
Friend ShoringOngoingMedium-HighGrowing efforts to 'friend shore' trade and investment could lead to the formation of exclusive new blocs, marginalising countries that do not wish to align with the major powers; friend
Read More

Quick View: Biogen Will Focus On Leqembi And Pipeline Alzheimer’s Drugs As It Drops Aduhelm

Pharmaceuticals / United States / Fri 02 Feb, 2024

The Latest: On January 31 2024, Biogen announced it will be discontinuing Alzheimer’s disease drug Aduhelm (aducanumab-avwa) by returning it to Neurimmune, its original owner, for a one-time charge of USD60mn. Biogen licensed Aduhelm from Neurimmune in 2007 under a collaborative development and license agreement. Aduhelm received FDA accelerated

Read More
Download Indicator Summary
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Clearbit Form
 

Thank you. Your download link will be emailed to you shortly.